Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents

After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents’ median post...

Descripción completa

Detalles Bibliográficos
Autores principales: Canaday, David H, Carias, Lenore, Oyebanji, Oladayo A, Keresztesy, Debbie, Wilk, Dennis, Payne, Michael, Aung, Htin, St. Denis, Kerri, Lam, Evan C, Rowley, Christopher F, Berry, Sarah D, Cameron, Cheryl M, Cameron, Mark J, Wilson, Brigid, Balazs, Alejandro B, Gravenstein, Stefan, King, Christopher L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240817/
https://www.ncbi.nlm.nih.gov/pubmed/33993265
http://dx.doi.org/10.1093/cid/ciab447
_version_ 1783715281094311936
author Canaday, David H
Carias, Lenore
Oyebanji, Oladayo A
Keresztesy, Debbie
Wilk, Dennis
Payne, Michael
Aung, Htin
St. Denis, Kerri
Lam, Evan C
Rowley, Christopher F
Berry, Sarah D
Cameron, Cheryl M
Cameron, Mark J
Wilson, Brigid
Balazs, Alejandro B
Gravenstein, Stefan
King, Christopher L
author_facet Canaday, David H
Carias, Lenore
Oyebanji, Oladayo A
Keresztesy, Debbie
Wilk, Dennis
Payne, Michael
Aung, Htin
St. Denis, Kerri
Lam, Evan C
Rowley, Christopher F
Berry, Sarah D
Cameron, Cheryl M
Cameron, Mark J
Wilson, Brigid
Balazs, Alejandro B
Gravenstein, Stefan
King, Christopher L
author_sort Canaday, David H
collection PubMed
description After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents’ median post–second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2–naive healthcare workers.
format Online
Article
Text
id pubmed-8240817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82408172021-06-30 Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents Canaday, David H Carias, Lenore Oyebanji, Oladayo A Keresztesy, Debbie Wilk, Dennis Payne, Michael Aung, Htin St. Denis, Kerri Lam, Evan C Rowley, Christopher F Berry, Sarah D Cameron, Cheryl M Cameron, Mark J Wilson, Brigid Balazs, Alejandro B Gravenstein, Stefan King, Christopher L Clin Infect Dis Brief Reports After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents’ median post–second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2–naive healthcare workers. Oxford University Press 2021-05-16 /pmc/articles/PMC8240817/ /pubmed/33993265 http://dx.doi.org/10.1093/cid/ciab447 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Canaday, David H
Carias, Lenore
Oyebanji, Oladayo A
Keresztesy, Debbie
Wilk, Dennis
Payne, Michael
Aung, Htin
St. Denis, Kerri
Lam, Evan C
Rowley, Christopher F
Berry, Sarah D
Cameron, Cheryl M
Cameron, Mark J
Wilson, Brigid
Balazs, Alejandro B
Gravenstein, Stefan
King, Christopher L
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title_full Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title_fullStr Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title_full_unstemmed Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title_short Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
title_sort reduced bnt162b2 messenger rna vaccine response in severe acute respiratory syndrome coronavirus 2 (sars-cov-2)–naive nursing home residents
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240817/
https://www.ncbi.nlm.nih.gov/pubmed/33993265
http://dx.doi.org/10.1093/cid/ciab447
work_keys_str_mv AT canadaydavidh reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT cariaslenore reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT oyebanjioladayoa reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT keresztesydebbie reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT wilkdennis reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT paynemichael reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT aunghtin reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT stdeniskerri reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT lamevanc reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT rowleychristopherf reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT berrysarahd reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT cameroncherylm reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT cameronmarkj reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT wilsonbrigid reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT balazsalejandrob reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT gravensteinstefan reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents
AT kingchristopherl reducedbnt162b2messengerrnavaccineresponseinsevereacuterespiratorysyndromecoronavirus2sarscov2naivenursinghomeresidents

Ejemplares similares